-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $105

Benzinga·09/08/2026 18:50:25
Listen to the news
Jefferies analyst Anthony Petrone maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price target from $88 to $105.